Collegium Pharmaceutical (COLL) Non-Current Deferred Tax Liability (2018)

Collegium Pharmaceutical's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $11.5 million for Q4 2018.

• On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $11.5 million in Q4 2018; TTM through Dec 2018 was $11.5 million, a N/A change from a year earlier, with the FY2018 full-year figure at $11.5 million, changed N/A from the prior year.
• Non-Current Deferred Tax Liability was little changed at $11.5 million in Q4 2018 per COLL's latest filing.
• Across five years, Non-Current Deferred Tax Liability topped out at $11.5 million in Q4 2018 and bottomed at $11.5 million in Q4 2018.